Saniya Exports & Imports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Saniya Exports & Imports Pharmaceutical Export Portfolio Dataset — 5 Products, $189.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Saniya Exports & Imports — Pharmaceutical Exporter Profile (2026) | 5 Products, $189.9K Trade | TransData Nexus

Saniya Exports & Imports

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $189.9K Total Trade · DGFT Verified

Saniya Exports & Imports is an Indian pharmaceutical exporter with a total trade value of $189.9K across 5 products in 1 therapeutic categories. Based on 473 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Taila ($108.6K), Arishta ($57.8K), Kwatha ($12.9K).

Saniya Exports & Imports — Export Portfolio & Destination Treemap

Saniya Exports & Imports pharmaceutical export portfolio — 5 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Saniya Exports & Imports? — Company Overview & Market Position

Saniya Exports & Imports, established in 2015, is a privately held Indian company specializing in the export of Ayurvedic and herbal pharmaceutical formulations. The company is headquartered at X/208/E, White House, Manjummal P.O., near Muttar Bridge, Ernakulam, Kerala, India. The proprietor of the company is Mr. Dalton Joseph. Saniya Exports & Imports has demonstrated a consistent growth trajectory, with a total export value of $190,000 USD and 473 shipments recorded between 2022 and 2026. The company exports five finished pharmaceutical formulations across a single therapeutic category, Ayurvedic & Herbal Products, with a portfolio concentration of 100% in this segment.

What Does Saniya Exports & Imports Export? — Product Portfolio Analysis

Top Products by Export Value

1Taila$108.6K 2Arishta$57.8K

Product Portfolio — Top 5 by Export Value

Saniya Exports & Imports exports 5 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Taila	Ayurvedic & Herbal Products	$108.6K	203	1.4%	7
2	Arishta	Ayurvedic & Herbal Products	$57.8K	152	2.6%	5
3	Kwatha	Ayurvedic & Herbal Products	$12.9K	49	2.4%	13
4	Ghrita	Ayurvedic & Herbal Products	$6.0K	40	0.7%	7
5	Asava	Ayurvedic & Herbal Products	$4.5K	29	1.0%	10

Saniya Exports & Imports exports 5 pharmaceutical products across 1 therapeutic categories with a total export value of $189.9K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Saniya Exports & Imports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding the manufacturing facilities of Saniya Exports & Imports are not publicly disclosed. The company exports finished pharmaceutical formulations, indicating that manufacturing is likely conducted in compliance with Good Manufacturing Practices (GMP) standards. However, without explicit information, a comprehensive assessment of their manufacturing capabilities cannot be provided.

3Key Leadership

The company is led by Mr. Dalton Joseph, who serves as the Proprietor. Specific information regarding other key executives, such as a Chief Executive Officer (CEO) or Chief Financial Officer (CFO), is not publicly available. The absence of detailed leadership information limits the ability to assess the company's executive structure and strategic direction.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Saniya Exports & Imports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Saniya Exports & Imports primarily exports Ayurvedic and herbal pharmaceutical formulations, which are subject to regulatory approvals in various markets. While the company has engaged in trade with the United Arab Emirates (UAE), specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. The lack of publicly accessible regulatory information restricts a comprehensive analysis of the company's presence in these regulated markets.

2Emerging Markets

Saniya Exports & Imports has engaged in trade with the United Arab Emirates (UAE), indicating a presence in the Middle East market. However, specific information regarding the company's penetration into African, Latin American, or Southeast Asian markets is not publicly available. The absence of data on WHO prequalification or other certifications that enable access to these regions limits the ability to assess the company's reach in emerging markets.

3Geographic Strategy

Saniya Exports & Imports has demonstrated a focused geographic strategy, primarily exporting to the United Arab Emirates (UAE). This concentration suggests a strategic emphasis on the Middle East market. The lack of diversification into other regions may expose the company to risks associated with over-reliance on a single market. A more diversified geographic strategy could mitigate potential risks and open avenues for growth in other regions.

Saniya Exports & Imports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Saniya Exports & Imports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not publicly available. The absence of such data limits the ability to assess the company's compliance with FDA regulations and its standing in the U.S. market.

2WHO & EU GMP

There is no publicly available information regarding Saniya Exports & Imports' WHO prequalification status, EU GMP certificates, or EDQM status. The lack of such certifications may impact the company's ability to access certain international markets that require adherence to these standards.

3CDSCO & Indian Regulatory

Specific details regarding Saniya Exports & Imports' CDSCO manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not publicly disclosed. The absence of this information limits the ability to assess the company's compliance with Indian regulatory requirements.

Saniya Exports & Imports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Saniya Exports & Imports operates in the Ayurvedic and herbal pharmaceutical formulations segment, exporting products such as Taila, Arishta, Kwatha, Ghrita, and Asava. While specific market share data is not available, the company's focus on this niche market positions it among competitors specializing in Ayurvedic and herbal products. The absence of publicly available data on competitors' market shares and product offerings limits a detailed competitive analysis.

2Key Differentiators

Saniya Exports & Imports' key differentiator lies in its specialization in Ayurvedic and herbal pharmaceutical formulations. The company's portfolio concentration of 100% in this segment indicates a deep focus and expertise in traditional medicine products. However, the lack of publicly available information on product quality certifications and regulatory approvals may impact the company's competitive advantage in certain markets.

3Strategic Position

Saniya Exports & Imports appears to be strategically positioned in the Ayurvedic and herbal pharmaceutical formulations market, with a concentrated product portfolio. The company's focus on this niche segment suggests a specialization strategy. However, the lack of diversification in product offerings and geographic markets may limit growth opportunities and expose the company to risks associated with market concentration.

Buyer Due Diligence Brief — Evaluating Saniya Exports & Imports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Saniya Exports & Imports has demonstrated a consistent export volume, with 473 shipments recorded between 2022 and 2026. The company's primary trading partner is Sabha General Trading Co LLC in the United Arab Emirates, indicating a stable business relationship. However, the absence of publicly available information on the company's financial stability, supply chain practices, and adherence to international quality standards limits a comprehensive assessment of its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Saniya Exports & Imports as a supplier:

FDA Facility Registration: To ensure compliance with U.S. regulations. Verification can be done through the FDA's official website.

WHO-GMP Certification: To confirm adherence to World Health Organization Good Manufacturing Practices. Verification can be done through the WHO's official website.

Frequently Asked Questions — Saniya Exports & Imports

How many pharmaceutical products does Saniya Exports & Imports export from India?

Saniya Exports & Imports exports 5 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($108.6K), Arishta ($57.8K), Kwatha ($12.9K), Ghrita ($6.0K), Asava ($4.5K). Total export value is $189.9K.

What is Saniya Exports & Imports's total pharmaceutical export value?

Saniya Exports & Imports's total pharmaceutical export value is $189.9K, based on 473 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Saniya Exports & Imports cover?

Saniya Exports & Imports exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 5 products).

Get Full Saniya Exports & Imports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.